Total intravenous anesthesia with propofol and remifentanil. Results of a multicenter study of 6,161 patients;Total intravenöse anästhesie mit propofol und remifentanil: Ergebnisse einer multizentrischen untersuchung an 6161 patienten

Anaesthesist

Volumn 54, Issue 1, 2005, Pages 17-28

  Schmidt, J ^a   Hering, W ^b   Albrecht, S ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b St Marien Krankenhaus Siegen gem GmbH   (Germany)

Author keywords

Assessment; Degree of acceptance; Propofol; Remifentanil; Total intravenous anesthesia

Indexed keywords

ALFENTANIL; ATRACURIUM; CISATRACURIUM; ETOMIDATE; MIDAZOLAM; MIVACURIUM; OPIATE; PANCURONIUM; PIRITRAMIDE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SUFENTANIL; SUXAMETHONIUM; THIOPENTAL; VECURONIUM;

ABDOMINAL SURGERY; ADULT; AGED; ANESTHESIA INDUCTION; ANESTHESIST; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FREQUENCY ANALYSIS; HEMODYNAMICS; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NURSING STAFF; ORTHOPEDIC SURGERY; PAIN; PERIOPERATIVE PERIOD; PHASE 4 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE NAUSEA AND VOMITING; QUALITY CONTROL; SAMPLE SIZE; SCORING SYSTEM; SHIVERING; SIDE EFFECT; SURGEON;

ABDOMEN; ADULT; AGED; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; ATRACURIUM; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; ORTHOPEDIC PROCEDURES; PATIENT SATISFACTION; PIPERIDINES; PROPOFOL; RETROSPECTIVE STUDIES;

EID: 14244255494     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-004-0787-9     Document Type: Article

References (45)

1. Albrecht S, Schuttler J, Yarmush J (1999) Postoperative pain management after intraoperative remifentanil. Anesth Analg 89 [Suppl 4]:S40-45
2. Albrecht S, Fechner J, Geisslinger G et al. (2000) Postoperative pain control following remifentanil-based anaesthesia for major abdominal surgery. Anaesthesia 55:315-322
3. Blobner M, Söhnel A-M, Roemer A van de et al. (2003) Anwendung von Muskelrelaxanzien in Deutschland - Eine Umfrage an allen Deutschen Anästhesieeinrichtungen. Anaesthesist 52:427-434
4. Borgeat A, Stirnemann HR (1998) Antiemetische Wirkung von Propofol. Anaesthesist 47:918-924
5. Cremer OL, Moons KG, Bouman EA, Kruijswijk JE, Smet AM de, Kalkman CJ (2001) Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 357:117-118
6. Davis PJ, Lerman J, Suresh S, McGowan FX, Cote CJ, Landsman I, Henson LG (1997) A randomized multicenter study of remifentanil compared with alfentanil, isoflurane, or propofol in anesthetized pediatric patients undergoing elective strabismus surgery. Anesth Analg 84:982-989
7. Ebert TJ, Muzi M, Berens R, Goff D, Kampine JP (1992) Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology 76:725-733
8. Egan TD, Lemmens HJ, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL (1993) The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 79:881-892
9. Fuchs-BuderT (1997) Neue Muskelrelaxanzien - Update Mivacurium, Rocuronium und Cisatracurium. Anaesthesist 46:350-359
10. Fuchs-Buder T, Hofmockel R, Geldner G, Diefenbach C, Ulm K, Blobner M (2003) Einsatz des neuromuskulären Monitorings in Deutschland. Anaesthesist 52:522-526
11. Geldner G, Diefenbach C, Fuchs-Buder T, Hofmockel R, Blobner M (2003) Anwendung von Muskelrelaxanzien zur Routineeinleitung in Deutschland. Anaesthesist 52:435-441
12. 2O-Inhalationsanästhesie. Anaesthesist 47:102-110
13. Hogue CW, Bowdle TA, O'Leary C et al. (1996) A multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery. Anesth Analg 83:279-285
14. Juckenhöfel S, Feisel C, Schmitt H J, Biedler A (1999) TIVA mit Propofol/Remifentanil oder balancierte Anästhesie mit Sevofluran/Fentanyl bei laparoskopischen Operationen. Anaesthesist 48:807-812
15. Klein SM, Hauser GJ, Anderson BD, Shad AT, Gootenberg JE, Dalton HJ, Hertzog JH (2003) Comparison of intermittent versus continuous infusion of propofol for elective oncology procedures in children. Pediatr Crit Care Med 4:78-82
16. Kovac AL, Azad SS, Steer P, Witkowski T, Batenhorst R, McNeal S (1997) Remifentanil versus alfentanil in a balanced anesthetic technique for total abdominal hysterectomy. J Clin Anesth 9:532-541
17. Lasagna K (1983) Discovering adverse drug reactions. JAMA 249:2224-2225
18. Lorenz W, Duda D, Dick W et al., Trial Group Mainz-Marburg (1994) Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia. Lancet 343:933-940
19. McLeskey CH, Walawander CA, Nahrwold ML et al. (1993) Adverse events in a multicenter phase IV study of propofol: evaluation by anesthesiologists and postanesthesia care unit nurses. Anesth Analg 77 [Suppl 4]:S3-9
20. Mellinghoff H, Diefenbach C (1997) Die klinische Pharmakologie von Cisatracurium. Anaesthesist 46:481-485
21. Mertes PM, Laxenaire MC, Alla F, Groupe d'Etudes des Réactions Anaphylactoïdes Peranesthésiques (2003) Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 99:536-545
22. Motsch J, Roggenbach J (2004) Propofol-Infusionsyndrom. Anaesthesist 53:1009-1024
23. Nahrwold ML, Roizen MF, Stanley TH et al. (1993) Phase IV study of propofol: validation of the data set. Anesth Analg 77 [Suppl 4]:S34-43
24. Nathan N, Debord J, Narcisse F et al. (1993) Pharmacokinetics of propofol and its conjugates after continuous infusion in normal and in renal failure patients: a preliminary study. Acta Anaesthesiol Belg 44:77-85
25. Pühringer FK, Scheller A, Kleinsasser A, Löckinger A, Keller P, Raedler C, Keller C (2000) Die Wirkung unterschiedlicher Primingdosen auf die Pharmakokinetik von Cisatracurium. Anaesthesist 49:102-105
26. Rodgers A, Walker N, Schug S et al. (2000) Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 321:1493-1505
27. Rowbotham DJ, Peacock JE, Jones RM et al. (1998) Comparison of remifentanil in combination with isoflurane or propofol for short-stay surgical procedures. Br J Anaesth 80:752-755
28. Schmidt J, Fechner J, Fritsch B, Schmitz B, Carbon R, Rösch W, Albrecht S (2001) Propofol/Remifentanil versus Sevofluran/Remifentanil zur Anästhesie bei Unterbaucheingriffen im Säuglings-, Kindes- und Jugendalter. Anaesthesist 50:757-766
29. Schuttler J, Albrecht S, Breivik H et al. (1997) A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anaesthesia 52:307-317
30. Servin F, Farinotti R, Haberer JP, Desmonts JM (1993) Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. Anesthesiology 78:657-665
31. Shafer A, Doze VA, Shafer SL, White PF (1998) Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 69:348-356
32. Shinohara K, Aono H, Unruh GK, Kindscher JD, Goto H (2000) Suppressive effects of remifentanil on hemodynamics in baro-denervated rabbits. Can J Anaesth 47:361-366
33. Short AM, Aun CS (1991) Haemodynamic effects of propofol in children. Anaesthesia 46:783-785
34. Simons PJ, Cockshott ID, Douglas EJ, Gordon EA, Hopkins K, Rowland M (1988) Disposition in male volunteers of a subanaesthetic intravenous dose of oil in water emulsion of 14C-propofol. Xenobiotica 18:429-440
35. Strauß MJ, Giest J (2003) Total intravenöse Anästhesie - Auf dem Weg zum Standardverfahren bei Kindern. Anaesthesist 52:763-777
36. Upton R, Ludbrook GL, Grant C et al. (1999) Cardiac output is a determinant of the initial concentrations of propofol after short-infusion administration. Anesth Analg 89:545-552
37. Vasile B, Rasulo F, Candiani A, Latronico N (2003) The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 29:1417-1425
38. Veroli P, O'Kelly B, Bertrand F, Trouvin JH, Farinotti R, Ecoffey C (1992) Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation. Br J Anaesth 68:183-186
39. Werdan U, Werdan K (1997) Der anaphylaktische Schock. Anaesthesist 46:549-563
40. Wilhelm W, Biedler A, Larsen R (1997) Remifentanil - Erste klinische Erfahrungen bei 3100 Patienten. Anaesthesist 46:992-997
41. Wilhelm W, Grüneß V, Kleinschmidt S, Larsen R (1998) Anästhesiekonzepte mit Remifentanil. Anaesthesiol Intensivmed 39:353-361
42. Wilhelm W, Khuenel-Brady K, Beaufort AM, Tassonyi E, Meistelman C (2000) Neuromuskuläres Monitoring: Vorgaben verschiedener nationaler Fachgesellschaften und deren Umsetzung in die Praxis. Anaesthesist 49 [Suppl 1]:S7-8
43. Wilhelm W, Wrobel M, Kreuer S, Larsen R (2003) Remifentanil. Eine Bestandsaufnahme. Anaesthesist 52:473-494
44. Wolf A, Weir P, Segar P, Stone J, Shield J (2001) Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 357:606-607
45. Wu CL, Naqibuddin M, Fleisher LA (2001) Measurement of patient satisfaction as an outcome of regional anesthesia and analgesia: a systematic review. Reg Anesth Pain Med 26:196-208